Neptune Wellness Solutions Inc. NEPTF
0.00
0.00
NaN
as of 23 Sep
- Market cap
- $1.6M
- P/E
- 0.0×
Follow NEPTF
Growth Flags
show if company had growth for consecutive years
| Older periods | Mar '23 | Jun '23 | Sep '23 | Dec '23 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.12 | 0.05 | 0.02 | 0.06 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(0.81) | (0.45) | 1.05 | (0.78) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.52 | 0.56 | 0.52 | 1.12 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(0.96) | (0.95) | (1.21) | (2.83) | |
EV/FCF |
(0.89) | (0.91) | (1.16) | (2.69) | |
Quick Ratio |
0.23 | 0.15 | 0.19 | 0.07 | |
Current Ratio |
0.57 | 0.48 | 0.47 | 0.23 | |
Net Debt/EBITDA |
(0.51) | (2.29) | (5.23) | (1.42) | |
Debt/Assets |
74.21% | 82.58% | 89.37% | 112.85% | |
Debt/Equity |
(0.83) | (0.71) | (0.70) | (0.50) | |
Asset Turnover |
0.77 | 0.73 | 0.92 | 0.90 | |
Operating CF/Net income |
0.30 | 0.64 | (0.85) | 0.17 | |
Capex/Depreciation |
(0.46) | (0.01) | (0.37) | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.27% | 0.21% | 0.28% | 0.01% | |
Selling, General and Administrative Expense of Revenue |
92.49% | 112.65% | 43.90% | 246.49% | |
Intangible Assets out of Total Assets |
0.13 | 0.13 | 0.13 | 0.16 | |
Share Based Compensation of Revenue |
5.53% | 5.80% | 5.35% | 5.70% | |
Graham Net Nets |
(5.48) | (17.91) | (56.44) | (24.88) | |
Graham Number |
757.43 | 727.88 | 386.74 | 180.58 | |
Earnings Yield |
(1,264.81%) | (4,568.06%) | (9,136.72%) | (21,622.13%) | |
Free Cash Flow Yield |
(480.73%) | (1,204.29%) | (2,485.86%) | (691.72%) | |
Revenue per Share |
41.14 | 26.24 | 13.51 | 1.77 | |
Operating CF per Share |
(26.74) | (13.08) | 1.17 | (0.71) | |
Capex per Share |
(1.12) | (0.01) | (0.12) | 0.00 | |
Free Cash Flow per Share |
(27.85) | (13.09) | 1.06 | (0.71) | |
Cash per Share |
6.81 | 3.45 | 7.37 | 0.29 | |
Shareholders Equity per Share |
(93.33) | (87.67) | (59.15) | (12.19) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(93.33) | (87.67) | (59.15) | (12.19) | |
Free Cash Flow |
(8.23) | (5.30) | 0.68 | (3.03) | |
Working Capital |
(17.48) | (25.03) | (26.31) | (56.82) | |
Capital Expenditures |
(0.33) | 0.00 | (0.08) | 0.00 | |
Net Current Asset Value |
(34.94) | (42.64) | (44.91) | (58.65) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.03 | 0.00 | 0.01 | 0.00 | |
Net Profit Margin |
(213.59%) | (78.23%) | (10.19%) | (233.55%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
7.55 | 6.08 | 4.77 | 4.41 | |
Average Payables |
24.88 | 25.39 | 26.40 | 26.68 | |
Average Inventory |
15.03 | 13.91 | 13.93 | 13.28 | |
Average Assets |
67.94 | 64.15 | 47.55 | 43.50 | |
Average Common Equity |
16.64 | 9.14 | (11.33) | (18.15) |
Columns are period end dates